UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response

Frontiers in oncology, 2024-09, Vol.14, p.1438052

2024

Volltextzugriff (PDF)

Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8

Cancers, 2023-07, Vol.15 (15), p.3822

2023

Volltextzugriff (PDF)

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis

Oncotarget, 2016-05, Vol.7 (21), p.30492-30503

2016

Volltextzugriff (PDF)

Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts

PloS one, 2015-05, Vol.10 (5), p.e0126555-e0126555

2015

Volltextzugriff (PDF)

Alteration in endoglin-related angiogenesis in refractory cytopenia with multilineage dysplasia

PloS one, 2013-01, Vol.8 (1), p.e53624-e53624

2013

Volltextzugriff (PDF)

P714: DISSECTING THE CLINICAL HETEROGENEITY OF ISOLATED TRISOMY 8 MYELODYSPLASTIC SYNDROMES THROUGH MUTATIONAL PROFILE

HemaSphere, 2023-08, Vol.7 (S3), p.e877555b-n/a

2023

Volltextzugriff (PDF)

Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients

The pharmacogenomics journal, 2020-10, Vol.20 (5), p.664-671

2020

Volltextzugriff (PDF)

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

Clinical and translational medicine, 2021-02, Vol.11 (2), p.e304-n/a

2021

Volltextzugriff (PDF)

Epigenetic Silencing of BCL2, ETS1, IL27RA and DICER1 in Low-Risk MDS Patients

Blood, 2012-11, Vol.120 (21), p.1704-1704

2012

Volltextzugriff (PDF)

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

Nature communications, 2024-03, Vol.15 (1), p.2428-2428, Article 2428

2024

Volltextzugriff (PDF)

Deconstructing myelodysplastic syndromes

Blood, 2019-07, Vol.134 (2), p.106-107

2019

Volltextzugriff (PDF)

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations

British journal of haematology, 2013-07, Vol.162 (1), p.74-86

2013

Volltextzugriff (PDF)

Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group

American journal of hematology, 2017-09, Vol.92 (9), p.E534-E541

2017

Volltextzugriff (PDF)

The prevalence of frailty syndrome in an older population from Spain. The Toledo study for healthy aging

The Journal of nutrition, health & aging, 2011-12, Vol.15 (10), p.852-856

2011

Volltextzugriff (PDF)

Wiskott-Aldrich syndrome in a child presenting with macrothrombocytopenia

Platelets (Edinburgh), 2017-06, Vol.28 (4), p.417-420

2017

Volltextzugriff (PDF)

Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT?

Blood, 2015-12, Vol.126 (23), p.2890-2890

2015

Volltextzugriff (PDF)

Design and Validate of Next-Generation Sequencing Panel for Inherited Platelet Disorders

Blood, 2014-12, Vol.124 (21), p.4210-4210

2014

Volltextzugriff (PDF)

Teratogenic effect of semicarbazide in Wistar rats

Biology of the neonate, 1986-01, Vol.49 (3), p.150-157

de la Fuente del Rey, M

1986

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Aktive Filter

KollektionAccess via ScienceDirect (Elsevier)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(142)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

16 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response

Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis

Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts

Alteration in endoglin-related angiogenesis in refractory cytopenia with multilineage dysplasia

P714: DISSECTING THE CLINICAL HETEROGENEITY OF ISOLATED TRISOMY 8 MYELODYSPLASTIC SYNDROMES THROUGH MUTATIONAL PROFILE

Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

Epigenetic Silencing of BCL2, ETS1, IL27RA and DICER1 in Low-Risk MDS Patients

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

Deconstructing myelodysplastic syndromes

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations

Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group

Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treated with Lenalidomide in the Sintra-Rev Clinical Trial: Safe and Effecitive Approach?

The prevalence of frailty syndrome in an older population from Spain. The Toledo study for healthy aging

Wiskott-Aldrich syndrome in a child presenting with macrothrombocytopenia

Sequential Study By RNA-Seq Shows a Reduction in Inflammation and a Cell Cycle Activation in T-Lymphocytes from Myelodysplastic Syndrome with Del(5q) after Lenalidomide Treatment in Patients Included in the “Sintra-REV” Clinical Trial

Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT?

Clinical Significance of Myelofibrotic (MF) Changes in Myelodysplastic Syndromes (MDS): A Prospective Evaluation Including Mutational Analysis By Next-Generation Sequencing (NGS)

Design and Validate of Next-Generation Sequencing Panel for Inherited Platelet Disorders

Results of the “Evaluation of NGS in AML-Diagnostics (ELAN)” Study – an Inter-Laboratory Comparison Performed in 10 European Laboratories

Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial

Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)

Teratogenic effect of semicarbazide in Wistar rats

Aktive Filter

Suchergebnisse filtern